Condensed Consolidated Statements of Cash Flows (Unaudited) (Parentheticals) $ in Millions |
9 Months Ended |
|---|---|
|
Sep. 30, 2023
USD ($)
| |
| Pieris Pharmaceuticals, Inc. [Member] | |
| Stock issuance costs | $ 0.7 |
| X | ||||||||||
- Definition The cash outflow for cost incurred directly with the issuance of an equity security. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|